Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1993 1
2005 2
2013 1
2014 2
2016 1
2018 2
2019 1
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
[Corticotropin-producing pheochromocytoma in multiple endocrine neoplasia type 1].
Rebrova DV, Grigorova SI, Vorokhobina NV, Zgoda EA, Novokshonov KY, Feofanova SG, Rusakov VF, Krasnov LM, Fedorov EA, Chinchuk IK, Shikhmagomedov SS, Pushkaruk AA, Sleptsov IV. Rebrova DV, et al. Among authors: vorokhobina nv. Probl Endokrinol (Mosk). 2023 Nov 11;69(5):55-64. doi: 10.14341/probl13260. Probl Endokrinol (Mosk). 2023. PMID: 37968952 Free PMC article. Russian.
[Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma].
Rebrova DV, Vorokhobina NV, Imyanitov EN, Rusakov VF, Krasnov LM, Sleptsov IV, Chernikov RA, Fedorov EA, Semenov AA, Chinchuk IK, Sablin IV, Alekseev MA, Kuleshov OV, Fedotov JN. Rebrova DV, et al. Among authors: vorokhobina nv. Probl Endokrinol (Mosk). 2021 Nov 15;68(1):8-17. doi: 10.14341/probl12834. Probl Endokrinol (Mosk). 2021. PMID: 35262293 Free PMC article. Russian.
Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas.
Shafigullina ZR, Velikanova LI, Vorokhobina NV, Shustov SB, Lisitsin AA, Malevanaia EV, Buinova MO, Bessonova EA, Kirsanov DO. Shafigullina ZR, et al. Among authors: vorokhobina nv. Steroids. 2018 Jul;135:31-35. doi: 10.1016/j.steroids.2018.04.006. Epub 2018 Apr 22. Steroids. 2018. PMID: 29689248 No abstract available.
Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
Velikanova LI, Shafigullina ZR, Lisitsin AA, Vorokhobina NV, Grigoryan K, Kukhianidze EA, Strelnikova EG, Krivokhizhina NS, Krasnov LM, Fedorov EA, Sablin IV, Moskvin AL, Bessonova EA. Velikanova LI, et al. Among authors: vorokhobina nv. Horm Cancer. 2016 Dec;7(5-6):327-335. doi: 10.1007/s12672-016-0267-0. Epub 2016 Jul 1. Horm Cancer. 2016. PMID: 27370636 Free PMC article.
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.
Gough SC, Bode B, Woo V, Rodbard HW, Linjawi S, Poulsen P, Damgaard LH, Buse JB; NN9068-3697 (DUAL-I) trial investigators. Gough SC, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):885-93. doi: 10.1016/S2213-8587(14)70174-3. Epub 2014 Sep 1. Lancet Diabetes Endocrinol. 2014. PMID: 25190523 Clinical Trial.
15 results